The trading week is expected to start in a big way this morning and investors are expected to be ready with their watch lists. One of the stocks which could be on the radars of investors in a big way this morning is the Biotricity Inc (OTC:BTCY) stock. The healthcare tech company announced its guidance for some financial periods yesterday.
The Details
The guidance was provided by Biotricity for the third quarter of the 2025 fiscal year that had ended on December 31, 2024. In the news release, the company noted that in the third fiscal quarter it had continued on its aims of developing innovative healthcare technology capable of driving transformation. At the same time, the technologies were also described as a demonstration of the company’s continued commitment to efficiency, automation and financial prudence. In the third quarter, the company continued to leverage its Biocure suite of products.
Key Information
One of the most important things announced by the company was with regards to the fact that it continued to be focussed on its primary objective of higher revenues and margins. There was widespread optimism about the performance that was delivered by Biotricity on the front in the quarter in question.
Key Quote
Dr. Waqaas Al-Siddiq, Biotricity Founder & CEO, said, “In the third quarter of fiscal 2025, we continued our mission to develop innovative transformative healthcare technologies, while demonstrating our strong commitment to automation, operating efficiency and financial discipline. Our primary focus remains on driving revenue and margins and as such, we were pleased to see these metrics trend upwards. This quarter we continued to leverage our Biocore suite of products, and the data collected, pushing the boundaries of what’s possible in healthcare outcomes through cutting-edge research and development. We continue our dedicated path of redefining medical diagnostics and patient care by introducing innovative AI-driven solutions.
Technicals
| +/- EMA(20) | 0.4 (+50.00%) |
| +/- SMA(50) | 0.35 (+71.43%) |
| +/- SMA(200) | 0.55 (+9.09%) |
| 5-Day Perf. | +71.43% |
| 1-Month Perf. | +71.43% |
| 3-Month Perf. | +42.86% |
| 6-Month Perf. | +49.44% |
| YTD Perf. | +107.04% |
| 1-Year Perf. | -38.14% |
| RSI(14) | 69.84 |
| ATR(14) | 0.08 |
| ADX(14) | 41.57 |
| Beta (5Y) | 1.16 |
